Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review

Pancreatology

Volumn 15, Issue 1, 2015, Pages 19-24

  Ozola Zalite, I ^a   Zykus, R ^b   Francisco Gonzalez, M ^c   Saygili, F ^d   Pukitis, A ^a,e   Gaujoux, S ^f,g   Charnley, R M ^h   Lyadov, V ⁱ  

^a PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^b LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^c Unidad de Enfermedades Infecciosas   (Spain)

^d PAMUKKALE UNIVERSITY   (Turkey)

^e UNIVERSITY OF LATVIA   (Latvia)

^f APHP ^*  (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h FREEMAN HOSPITAL   (United Kingdom)

ⁱ N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

Cachexia; Malnutrition; Pancreatic adenocarcinoma; Pancreatic neoplasm; Sarcopenia; Survival

Indexed keywords

ARTICLE; BODY MASS; CACHEXIA; CANCER PATIENT; CANCER SURVIVAL; COCHRANE LIBRARY; CONSENSUS; DISEASE ASSOCIATION; HUMAN; MEDICAL LITERATURE; MEDLINE; OBESITY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SARCOPENIA; SYSTEMATIC REVIEW; WEIGHT REDUCTION; COMPLICATION; MORTALITY; PANCREAS CARCINOMA; PANCREAS TUMOR; PREVALENCE; PROGNOSIS; SURVIVAL RATE;

CACHEXIA; CARCINOMA, PANCREATIC DUCTAL; HUMANS; PANCREATIC NEOPLASMS; PREVALENCE; PROGNOSIS; SARCOPENIA; SURVIVAL RATE; WEIGHT LOSS;

EID: 84922930554     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2014.11.006     Document Type: Review

References (34)

1. K. Fearon, F. Strasser, S.D. Anker, I. Bosaeus, E. Bruera, and R.L. Fainsinger Definition and classification of cancer cachexia: an international consensus Lancet Oncol 12 5 2011 489 495
2. S. Lucia, M. Esposito, F. Rossi Fanelli, and M. Muscaritoli Cancer cachexia: from molecular mechanisms to patient's care Crit Rev Oncog 17 3 2012 315 321
3. E.A. Holly, I. Chaliha, P.M. Bracci, and M. Gautam Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area Clin Gastroenterol Hepatol 2 2004 510 517
4. V.E. Baracos, T. Reiman, M. Mourtzakis, I. Gioulbasanis, and S. Antoun Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis Am J Clin Nutr 91 Suppl. 2010 1133S 1137S
5. O. Mir, R. Coriat, B. Blanchet, J.P. Durand, P. Boudou-Rouquette, and J. Michels Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma PLoS One 7 5 2012 e37563
6. O. Mir, R. Coriat, M. Dhooge, G. Perkins, P. Boudou-Rouquette, and C. Brezault Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2 Anticancer Drugs 23 7 2012 739 744
7. L. Martin, L. Birdsell, N. MacDonald, T. Reiman, M.T. Clandinin, and L. McCargar Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index J Clin Oncol 31 12 2013 1539 1547
8. B.S. Miller, K.M. Ignatoski, S. Daignault, C. Lindland, M. Doherty, and P.G. Gauger Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinoma World J Surg 36 7 2012 1509 1516
9. S.J. Wigmore, C.E. Plester, R.A. Richardson, and K.C. Fearon Changes in nutritional status associated with unresectable pancreatic cancer Br J Cancer 75 1997 106 109
10. A. Viganó, E. Bruera, G.S. Jhangri, S.C. Newman, A.L. Fields, and M.E. Suarez-Almazor Clinical survival predictors in patients with advanced cancer Arch Intern Med 160 2000 861 868
11. W.D. Dewys, C. Begg, P.T. Lavin, P.R. Band, J.M. Bennett, and J.R. Bertino Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group Am J Med 69 1980 491 497
12. K.M. Di Sebastiano, L. Yang, K. Zbuk, R.K. Wong, T. Chow, and D. Koff Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia Br J Nutr 109 2013 302 312
13. B.H.L. Tan, L.A. Birdsell, L. Martin, V.E. Baracos, and K.C.H. Fearon Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer Clin Cancer Res 15 22 2009
14. S. Dalal, D. Hui, L. Bidaut, K. Lem, E. Del Fabbro, and C. Crane Relationships among body mass index, longitudinal body composition alterations and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study J Pain Symptom Manage 44 2012 181 191
15. K.C. Fearon, A.C. Voss, and D.S. Hustead Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis Am J Clin Nutr 83 2006 1345 1350
16. J. Bachmann, M. Heiligensetzer, H. Krakowski-Roosen, M.W. Büchler, H. Friess, and M.E. Martignoni Cachexia worsens prognosis in patients with resectable pancreatic cancer J Gastrointest Surg 12 2008 1193 1201
17. T. Pausch, W. Hartwig, U. Hinz, T. Swolana, B.D. Bundy, and T. Hackert Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer Surgery 152 2012 S81 S88
18. A. Aslani, A.J. Gill, P.J. Roach, B.J. Allen, and R.C. Smith Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure HPB Oxf 12 2010 325 333
19. N. Papadoniou, C. Kosmas, K. Gennatas, A. Polyzos, D. Mouratidou, and E. Skopelitis Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis Anticancer Res 28 1B 2008 Jan-Feb 543 549
20. M.H. Jamal, S.A. Doi, E. Simoneau, J. Abou Khalil, M. Hassanain, and P. Chaudhury Unresectable pancreatic adenocarcinoma: do we know who survives? HPB Oxf 12 8 2010 Oct 561 566
21. F. Tas, F. Sen, H. Odabas, L. KIlIc, S. KeskIn, and I. YIldIz Performance status of patients is the major prognostic factor at all stages of pancreatic cancer Int J Clin Oncol 18 5 2013 Oct 839 846
22. D.R. Thomas Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia Clin Nutr 26 2007 389 399
23. W.J. Evans, J.E. Morley, J. Argilés, C. Bales, V. Baracos, and D. Guttridge Cachexia: a new definition Clin Nutr 27 2008 793 799
24. J.E. Morley, S.D. Anker, and W.J. Evans Cachexia and aging: an update based on the fourth international cachexia meeting J Nutr Health Aging 13 2009 47 55
25. W.J. Durham, E.L. Dillon, and M. Sheffield-Moore Inflammatory burden and amino acid metabolism in cancer cachexia Curr Opin Clin Nutr Metab Care 12 2009 72 77
26. C.M. Prado, J.R. Lieffers, L.J. McCargar, T. Reiman, M.B. Sawyer, and L. Martin Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study Lancet Oncol 9 2008 629 635
27. N.B. Kumar, A. Kazi, T. Smith, T. Crocker, D. Yu, and R.R. Reich Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment Curr Treat Options Oncol 3-4 2010 Dec 11 107 117
28. A.J. Cruz-Jentoft, J.P. Baeyens, J.M. Bauer, Y. Boirie, T. Cederholm, and F. Landi Sarcopenia: European consensus on definition and diagnosis report of the European Working Group on Sarcopenia in Older People Age Ageing 39 2010 412 423
29. B.H. Goodpaster, S.W. Park, T.B. Harris, S.B. Kritchevsky, M. Nevitt, and A.V. Schwartz The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study J Gerontol A Biol Sci Med Sci 61 2006 1059 1064
30. M.J. Delmonico, T.B. Harris, J.S. Lee, M. Visser, M. Nevitt, and S.B. Kritchevsky Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women J Am Geriatr Soc 55 2007 769 774
31. C.M. Prado, V.E. Baracos, L.J. McCargar, T. Reiman, M. Mourtzakis, and K. Tonkin Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment Clin Cancer Res 15 8 2009 Apr 15 2920 2926
32. S. Antoun, V.E. Baracos, L. Birdsell, B. Escudier, and M.B. Sawyer Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma Ann Oncol 21 8 2010 1594 1598
33. E. Parkin, A.A. Plumb, D. O'Reilly, and A.G. Renehan Body composition and outcome in patients undergoing resection of colorectal liver metastases Br J Surg 99 2012 550 555
34. H.A. Parsons, V.E. Baracos, N. Dhillon, D.S. Hong, and R. Kurzrock Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service PLoS One 7 1 2012 e29330